Clinical Trials Insight: 700051726
Phase of Trial: Phase I/II
Latest Information Update: 21 Jan 2011
At a glance
- Drugs Azacitidine (Primary)
- Indications Myelodysplastic syndromes
- Focus Registrational; Therapeutic Use
- Sponsors Nippon Shinyaku
- 21 Jan 2011 Azacitidine has been approved for treatment of myelodysplastic syndromes based on results of this and other trials.
- 16 Dec 2009 New trial record.